Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03530098 · ClinicalTrials.gov registry record · NA
Validation of an Artificial Intelligence-based Algorithm for Skeletal Age Assessment
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 1,903
- Enrollment target
NCT03530098: Completed NA study, sponsored by Stanford University.
NCT03530098 is a NA study that has completed, run by Stanford University. The registered enrollment target is 1,903 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (36% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03530098, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,903 participants
- Enrollment target
Study Summary
The purpose of this study is to understand the effects of using an Artificial Intelligence algorithm for skeletal age estimation as a computer-aided diagnosis (CADx) system. In this prospective real-time study, the investigators will send de-identified hand radiographs to the Artificial Intelligence algorithm and surface the output of this algorithm to the radiologist, who will incorporate this information with their normal workflows to make an estimation of the bone age. All radiologists involved in the study will be trained to recognize the surfaced prediction to be the output of the Artificial Intelligence algorithm. The radiologists' diagnosis will be final and considered independent to the output of the algorithm.
Primary Outcome
Mean absolute difference between dictated final impressions (baseline measure by Radiologist) and the consensus determination of a panel of radiologists following review.
Interventions
- DEVICE BoneAgeModel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,903 participants |
| Start Date | 2018-07-12 |
| Est. Completion | 2019-08-31 |
| Phase | NA |
What the finished NCT03530098 record still lists
NCT03530098 is an interventional study that assigns participants to a tested intervention. Its 1,903 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (36% higher).
The record links to 0 conditions, and to 1 intervention - of which BoneAgeModel is the first listed.
NCT03530098 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03530098 about?
NCT03530098 is a clinical study titled "Validation of an Artificial Intelligence-based Algorithm for Skeletal Age Assessment". The purpose of this study is to understand the effects of using an Artificial Intelligence algorithm for skeletal age estimation as a computer-aided diagnosis (CADx) system. In this prospective real-time study, the investigators will send de-identified hand radiographs to the Artificial Intelligence...
What is the current status of trial NCT03530098?
This trial is currently completed. It is a NA study. The enrollment target is 1,903 participants. The study started on 2018-07-12. Estimated completion is 2019-08-31.
What interventions are being tested in trial NCT03530098?
The interventions under investigation include: BoneAgeModel (DEVICE).
Who is sponsoring clinical trial NCT03530098?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03530098's enrollment target sits among peer trials
1,903 55th of 2000 higher than 1,946 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03729180 · 1,900 participants · NA
The ImPreSS Trial: Pharmacogenomic Decision Making at Time of Surgery
- NCT05712200 · 1,900 participants · Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- NCT06929806 · 1,900 participants · Phase 3
Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
- NCT07228234 · 1,900 participants · NA
Evaluating Mammography Communication Approaches
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI